Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Protara Therapeutics launches $75 million public stock offering
-
Protara Announces Proposed Public Offering
-
Protara Therapeutics to Participate in Upcoming Investor Conferences
-
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
-
Protara Announces Closing of $100 Million Public Offering
-
Protara Announces Pricing of $100 Million Public Offering
-
Protara Therapeutics (TARA) Announces Proposed Public Offering
-
Protara Announces Proposed Public Offering
-
TD Cowen Reiterates Buy Rating on Protera Therapeutics (TARA)
-
TD Cowen Reiterates Buy Rating on Protera Therapeutics (TARA)
-
TD Cowen Reiterates Buy Rating on Protera Therapeutics (TARA)
-
Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit
-
TD Cowen Reiterates Buy Rating on Protera Therapeutics (TARA)
-
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
-
Protara Therapeutics to Participate in Upcoming Investor Conferences
-
Protara Therapeutics to Participate in Upcoming Investor Conferences
-
Pre-Open Stock Movers 10/12: (RRD) (TARA) (QTRX) Higher; (CVAC) (RLAY) (TREX) Lower (more...)
-
Protara Therapeutics Announces Pricing of $147.6 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
-
ArTara Therapeutics Inc. (TARA) Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
-
Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock

